THE DUBERSTEIN GROUP INC. for PFIZER INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
21st Century Cures - HR 6, 21st Century Cures Act. Opioids - HR 2578, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2016; HR 5393, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2017; S 2837, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2017; S 524, Comprehensive Addiction and Recovery Act of 2016.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KENNETH DUBERSTEIN | — |
| DANIEL P MEYER | — |
| DAVID J SCHIAPPA | — |
Medicare/Medicaid MMM
Medicare reimbursement rates/Medicare Part B.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL P MEYER | — |
Tariff (miscellaneous tariff bills) TAR
Miscellaneous tariffs bill - HR 4923, American Manufacturing Competitiveness Act of 2016; S 2794, American Manufacturing Competitiveness Act of 2016.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL P MEYER | — |
| DAVID J SCHIAPPA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.